Title |
Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)
|
---|---|
Published in |
Cochrane database of systematic reviews, April 2012
|
DOI | 10.1002/14651858.cd002744.pub4 |
Pubmed ID | |
Authors |
Kay Wang, Matthew Shun‐Shin, Peter Gill, Rafael Perera, Anthony Harnden |
Abstract |
During epidemics, influenza attack rates in children may exceed 40%. Options for prevention and treatment currently include the neuraminidase inhibitors zanamivir and oseltamivir. Laninamivir octanoate, the prodrug of laninamivir, is currently being developed. |
X Demographics
The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 23% |
United Kingdom | 2 | 15% |
Japan | 2 | 15% |
Spain | 1 | 8% |
Unknown | 5 | 38% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 11 | 85% |
Practitioners (doctors, other healthcare professionals) | 1 | 8% |
Scientists | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 176 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
India | 1 | <1% |
South Africa | 1 | <1% |
Unknown | 173 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 30 | 17% |
Student > Master | 26 | 15% |
Student > Ph. D. Student | 21 | 12% |
Researcher | 18 | 10% |
Other | 10 | 6% |
Other | 28 | 16% |
Unknown | 43 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 56 | 32% |
Nursing and Health Professions | 23 | 13% |
Psychology | 7 | 4% |
Agricultural and Biological Sciences | 7 | 4% |
Social Sciences | 6 | 3% |
Other | 23 | 13% |
Unknown | 54 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2021.
All research outputs
#1,879,366
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#4,026
of 11,842 outputs
Outputs of similar age
#10,573
of 174,458 outputs
Outputs of similar age from Cochrane database of systematic reviews
#44
of 179 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,458 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 179 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.